Literature DB >> 10465027

The role of the IGF-I receptor in the growth and transformation of mammalian cells.

R Baserga1, C Sell, P Porcu, M Rubini.   

Abstract

Recent developments in the molecular biology of the insulin-like growth factor I (IGF-I) receptor have clarified its role in cellular growth and transformation. Although cells homozygous for a targeted disruption of the IGF-I receptor genes can grow in serum-supplemented medium, the IGF-I receptor is required for optimal growth, and is required equally in all phases of the cell cycle. The receptor plays an even more stringent role in cellular transformation and tumorigenicity, which seem to be dependent on its normal expression in several cell types. The expression of both the IGF-I receptor and its ligands is regulated by other growth factors (especially PDGF and EGF), by oncogenes (like SV40 T antigen and c-myb) and by tumour suppressor genes (like WT1 and RB). The picture emerging from these studies is that several transforming agents may exert their growth promoting effects through the direct or indirect activation of the IGF autocrine loop.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 10465027     DOI: 10.1111/j.1365-2184.1994.tb01406.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  37 in total

Review 1.  IGF and insulin action in the mammary gland: lessons from transgenic and knockout models.

Authors:  D L Hadsell; S G Bonnette
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-01       Impact factor: 2.673

2.  Angiotensin II stimulates transcription of insulin-like growth factor I receptor in vascular smooth muscle cells: role of nuclear factor-kappaB.

Authors:  Yewei Ma; Liping Zhang; Tao Peng; Jizhong Cheng; Shilpa Taneja; Jiqiang Zhang; Patrice Delafontaine; Jie Du
Journal:  Endocrinology       Date:  2005-12-01       Impact factor: 4.736

3.  Molecular and functional characterizations of the association and interactions between nucleophosmin-anaplastic lymphoma kinase and type I insulin-like growth factor receptor.

Authors:  Bin Shi; Deeksha Vishwamitra; J Gabrielle Granda; Thomas Whitton; Ping Shi; Hesham M Amin
Journal:  Neoplasia       Date:  2013-06       Impact factor: 5.715

Review 4.  Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

5.  Identification of an autocrine mechanism for regulating cell-cycle progression in murine keratinocytes.

Authors:  G M Curtin; S M Fischer; T J Slaga
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

6.  Effect of IL-1β, TNF-α and IGF-1 on trans-endothelial passage of synthetic vectors through an in vitro vascular endothelial barrier of striated muscle.

Authors:  J P Gomez; C Gonçalves; C Pichon; P Midoux
Journal:  Gene Ther       Date:  2017-05-15       Impact factor: 5.250

7.  Role of the insulin-like growth factor I/insulin receptor substrate 1 axis in Rad51 trafficking and DNA repair by homologous recombination.

Authors:  Joanna Trojanek; Thu Ho; Luis Del Valle; Michal Nowicki; Jin Ying Wang; Adam Lassak; Francesca Peruzzi; Kamel Khalili; Tomasz Skorski; Krzysztof Reiss
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

8.  Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts.

Authors:  C Sell; G Dumenil; C Deveaud; M Miura; D Coppola; T DeAngelis; R Rubin; A Efstratiadis; R Baserga
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

9.  Anti-insulin growth factor receptor therapy in Ewing sarcoma.

Authors:  Michael S Isakoff; Neyssa Marina
Journal:  F1000 Med Rep       Date:  2009-08-17

10.  Growth factor receptors signaling in glioblastoma cells: therapeutic implications.

Authors:  Mia Carapancea; Oana Alexandru; Ani S Fetea; Laura Dragutescu; Juan Castro; Ada Georgescu; A Popa-Wagner; Magnus L Bäcklund; Rolf Lewensohn; Anica Dricu
Journal:  J Neurooncol       Date:  2008-11-30       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.